The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
The multifaceted role of reactive oxygen species in tumorigenesis
Open accessAbstract
Redox homeostasis is an essential requirement of the biological systems for performing various normal cellular functions including cellular growth, differentiation, senescence, survival and aging in humans. The changes in the basal levels of reactive oxygen species (ROS) are detrimental to cells and often lead to several disease conditions including cardiovascular, neurological, diabetes and cancer. During the last two decades, substantial research has been done which clearly suggests that ROS are essential for the initiation, progression, angiogenesis as well as metastasis of cancer in several ways. During the last two decades, the potential of dysregulated ROS to enhance tumor formation through the activation of various oncogenic signaling pathways, DNA mutations, immune escape, tumor microenvironment, metastasis, angiogenesis and extension of telomere has been discovered. At present, surgery followed by chemotherapy and/or radiotherapy is the major therapeutic modality for treating patients with either early or advanced stages of cancer. However, the majority of patients relapse or did not respond to initial treatment. One of the reasons for recurrence/relapse is the altered levels of ROS in tumor cells as well as in cancer-initiating stem cells. One of the critical issues is targeting the intracellular/extracellular ROS for significant antitumor response and relapse-free survival. Indeed, a large number of FDA-approved anticancer drugs are efficient to eliminate cancer cells and drug resistance by increasing ROS production. Thus, the modulation of oxidative stress response might represent a potential approach to eradicate cancer in combination with FDA-approved chemotherapies, radiotherapies as well as immunotherapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS play an essential role in carcinogenesis, affecting multiple biological processes, including genomic instability, cell growth, angiogenesis, inflammation, metabolic reprogramming, metastatization, and resistance to apoptosis [77].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [77]
In the citing paper
“Elevated levels of intracellular ROS are known to be one of the reasons for genomic instability and, hence, carcinogenesis [29].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
In the citing paper
“ROS are known to play a multifaced, opposing role in cancer, by favoring cancer onset at low doses on the one hand, and killing tumors at high doses on the other hand [29,55].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
Citations
Cites
2 retracted
Garg, M., Kanojia, D., Mayakonda, A., Ganesan, T. S., Sadhanandhan, B., Suresh, S., Sneha, S., Nagare, R. P., SAID, J. W., Doan, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10325-x · Cited by 48
Self-citationRetractedKanojia, D., Garg, M., Martinez, J., Anand, M. T., Luty, S. B., Doan, N., SAID, J. W., Forscher, C. A., Tyner, J. W., & Koeffler, H. P. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0540-x · Cited by 30
Self-citationRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Cited by
Sorted by citations
Items 101–200 of 452
Vekić, J., Zeljković, A., Stefanović, A., Giglio, R. V., Ciaccio, M., & Rizzo, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212409 · Cited by 52
Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms
Lyubitelev, A. V., & Studitsky, V. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310663 · Cited by 53
“Aside from mistakes made by replicative DNA polymerase during each S-period, there are also a multitude of sources of highly reactive compounds within the cells, such as reactive oxygen species [18].”
BackgroundWnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target
Zhao, Z., Cui, T., Wei, F., Zhou, Z., Sun, Y., Gao, C., Xu, X., & Zhang, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1367364 · Cited by 47
Wang, Y., Liu, X., Huang, W., Liang, J., & Chen, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108303 · Cited by 44
Wu, C., Mao, J., Wang, X., Yang, R., Wang, C., Li, C., & Zhou, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02058-z · Cited by 44
“ROS refers to a group of chemically active oxygenated substances, mainly including superoxide anion (O 2 · − ), hydroxyl radical (·OH), peroxyl radical (ROO·), hydrogen peroxide (H 2 O 2 ), ozone (O 3 ), and hypochlorous acid (HOCL) [15–18].”
BackgroundRecent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation
Yao, L., Zhu, X., Shan, Y., Zhang, L., Yao, J., & Xiong, H. (2024) · Small · doi:10.1002/smll.202310018 · Cited by 45
Monoamine oxidases: A missing link between mitochondria and inflammation in chronic diseases ?
Beucher, L., Gabillard-Lefort, C., Baris, O. R., & Mialet‐Perez, J. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103393 · Cited by 45
“ROS are important inducers of tumorigenesis through the stimulation of proliferation, the induction of metabolic reprogramming that provides necessary nutrients to sustain high growth and the promotion of endothelial-to-mesenchymal transition, migration and angiogenesis [121].”
BackgroundTewari, D., Priya, A., Bishayee, A., & Bishayee, A. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.795 · Cited by 46
Vitamin D Promotes Ferroptosis in Colorectal Cancer Stem Cells via SLC7A11 Downregulation
Guo, S., Zhao, W., Zhang, W., Li, S., Teng, G., & Liu, L. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/4772134 · Cited by 43
“ROS production and aberrant lipid and iron metabolism are some of the physiological differences between cancer and normal cells [6].”
BackgroundCatalano, T., Selvaggi, F., Cotellese, R., & Aceto, G. M. (2025) · Cancers · doi:10.3390/cancers17050752 · Cited by 43
“Furthermore, activation of antioxidant and detoxification systems allows tumor cells to tolerate high levels of ROS and escape cell death by systemic immune deregulation [91,92].”
Redox interactions-induced cardiac toxicity in cancer therapy
Fu, X., Tang, J., Wen, P., Huang, Z., & Najafi, M. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108952 · Cited by 43
Paskeh, M. D. A., Asadi, S., Zabolian, A., Saleki, H., Khoshbakht, M. A., Sabet, S., Naghdi, M. J., Hashemi, M., Hushmandi, K., Ashrafizadeh, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111669 · Cited by 43
Self-citationTuli, H. S., Mistry, H., Kaur, G., Aggarwal, D., Garg, V. K., Mittal, S., Yerer, M. B., Sak, K., & Khan, M. A. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666211119085834 · Cited by 43
Ma, W., Wang, Z., Zhao, Y., Wang, Q., Zhang, Y., Pan, L., Lu, W., Yan, S., Zhou, J. Y., Li, X., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6614574 · Cited by 43
“Redox homeostasis plays an essential role in cellular functions and is also involved in the progress of cancer [15].”
BackgroundMasood, S., Rehman, A. U., Bashir, S., El‐Shazly, M., Imran, M., Khalil, P., Iftikhar, F., Jaffar, H. M., & Khursheed, T. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00770-x · Cited by 42
“The mechanisms involved in ROS production not only includes auto-oxidative and non-enzymatic glycosylation but also the metabolic stress that results from altered energy metabolism, raised levels of inflammatory mediators, and poor status of the antioxidant defense system [6].”
BackgroundPaskeh, M. D. A., Asadi, A., Mirzaei, S., Hashemi, M., Entezari, M., Raesi, R., Hushmandi, K., Zarrabi, A., Ertaş, Y. N., Aref, A. R., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110323 · Cited by 41
The Redox Paradox: Cancer’s Double-Edged Sword for Malignancy and Therapy
Ranbhise, J. S., Singh, M. K., Ju, S., Han, S., Yun, H. R., Kim, S. S., & Kang, I. (2025) · Antioxidants · doi:10.3390/antiox14101187 · Cited by 44
“First, cancer cells dramatically increase their endogenous ROS production through oncogenic signaling [13].”
Venom peptides in cancer therapy: An updated review on cellular and molecular aspects
Mirzaei, S., Fekri, H. S., Hashemi, F., Hushmandi, K., Mohammadinejad, R., Ashrafizadeh, M., Zarrabi, A., & Garg, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105327 · Cited by 42
Self-citationLi, Y., He, P., Liu, Y., Qi, M., & Dong, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708093 · Cited by 42
The role and pharmacological characteristics of ATP-gated ionotropic receptor P2X in cancer pain
Zhang, W., Luo, C. H., Pu, F.-Q., Zhu, J., & Zhu, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105106 · Cited by 40
Mohan, C. D., Liew, Y. Y., Jung, Y. Y., Rangappa, S., Preetham, H. D., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., Lin, Z., Rangappa, K. S., et al. (2021) · Biochimie · doi:10.1016/j.biochi.2021.01.009 · Cited by 40
Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders
Su, Z., Guo, Y., Huang, X., Feng, B. C., Tang, L., Zheng, G., & Zhu, Y. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.686820 · Cited by 40
Surface Bio‐engineered Polymeric Nanoparticles
Haidar, L. L., Bilek, M., & Akhavan, B. (2024) · Small · doi:10.1002/smll.202310876 · Cited by 44
Mohamed, A. A., Zaghloul, R. A., Abdelghany, A. M., & Gayar, A. M. E. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22989 · Cited by 39
Tuli, H. S., Garg, V. K., Mehta, J. K., Kaur, G., Mohapatra, R. K., Dhama, K., Sak, K., Kumar, A., Varol, M., Aggarwal, D., et al. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s366630 · Cited by 43
“This can result in DNA damage and oncogenic mutations being incorporated into normal cells leading to genomic instability, and finally cancer.(89) Due to the phenolic hydroxyl structure of chalcones, they act as proton donors and combine with a radical to prevent oxidative damage.”
BackgroundSelf-citationQin, T., Feng, D., Zhou, B., Bai, L., & Yin, Y. (2022) · Antioxidants · doi:10.3390/antiox11102012 · Cited by 35
“GSH has been shown to be converted into GSSG to execute antioxidant functions [40,41].”
BackgroundHou, Y., Wang, H., Wu, J., Guo, H., & Chen, X. (2024) · Medicinal Research Reviews · doi:10.1002/med.22018 · Cited by 39
“98,101 Furthermore, mROS are required for KRAS ‐ driven lung carcinogenesis through regulation of the ERK/MAPK signaling pathway.”
BackgroundOxidative Stress in Cutaneous Lichen Planus—A Narrative Review
Georgescu, S. R., Mitran, C. I., Mitran, M. I., Nicolae, I., Matei, C., Ene, C. D., Popa, G. L., & Tampa, M. Ş. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122692 · Cited by 37
“However, peroxisomes may participate in the pro uction of ROSs via β-oxidation of the fatty acids [12,13].”
BackgroundFiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023) · Cells · doi:10.3390/cells12162048 · Cited by 39
“ROS play an essential role in carcinogenesis, affecting multiple biological processes, including genomic instability, cell growth, angiogenesis, inflammation, metabolic reprogramming, metastatization, and resistance to apoptosis [77].”
BackgroundInfluentialBasal Gp78-dependent mitophagy promotes mitochondrial health and limits mitochondrial ROS
Alan, P., Vandevoorde, K. R., Joshi, B., Cardoen, B., Gao, G., Mohammadzadeh, Y., Hamarneh, G., & Nabi, I. R. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04585-8 · Cited by 36
“ROS are critical for tumor initiation and progression acting through activation of oncogenic signaling and DNA mutation; at the same time, increasing ROS production eliminates cancer cells by inducing cell death programs [71].”
BackgroundMuhammad, W., Saeed, F., Afzaal, M., Niaz, B., Raza, M. A., Hussain, M., Tufail, T., Rasheed, A., Ateeq, H., & Jbawi, E. M. A. (2022) · International Journal of Food Properties · doi:10.1080/10942912.2022.2143522 · Cited by 34
“Further, Tlili et al.[31,32] reported that folk medicinal plant (P. ovata) extract showed FRAP was 0.17 ± 0.012 and 0.20 ± 0.006 EC 50 mg/ml of 70% methanol and 70% acetone extracts, respectively, and DPPH assay showed the value 0.56 ± 0.01 and 0.48 ± 0.004 EC 50 mg/ml of 70% methanol and 70% acetone extracts, respect…”
BackgroundInfluentialAl‐Khayal, K., Vaali‐Mohammed, M., Elwatidy, M., Traiki, T. B., Al-Obeed, O. A., Azam, M., Khan, Z., Abdulla, M., & Ahmad, R. (2020) · BMC Cancer · doi:10.1186/s12885-020-07165-w · Cited by 35
“Cancer cells are known to produce higher amount of ROS than normal cells, treating cancer cells with these ROS generating agents would insult these cells and leads to cell death [51].”
BackgroundGiacosa, S., Pillet, C., Séraudie, I., Guyon, L., Wallez, Y., Roelants, C., Battail, C., Evrard, B., Chalmel, F., Barette, C., et al. (2021) · Cancers · doi:10.3390/cancers13030576 · Cited by 43
“The cell migration assay was performed as described in Reference [49].”
BackgroundInfluentialRepurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer
Kerkhove, L., Geirnaert, F., Rifi, A. L., Ka, L. L., Gutiérrez, A., Oudaert, I., Corbet, C., Gevaert, T., Dufait, I., & Ridder, M. D. (2023) · Cancers · doi:10.3390/cancers15082363 · Cited by 38
Pharmacological approaches for targeting lysosomes to induce ferroptotic cell death in cancer
Ji, F., Wang, Z.-X., Bin, J.-L., Chen, Y., Ma, J., Deng, J.-H., Huang, X., Zhou, J., & Lu, G. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216728 · Cited by 38
Catalano, T., D’Amico, E., Moscatello, C., Marcantonio, M. C. D., Ferrone, A., Bologna, G., Selvaggi, F., Lanuti, P., Cotellese, R., Curia, M. C., et al. (2021) · Cancers · doi:10.3390/cancers13236045 · Cited by 34
“Therefore, it is very important to explore the modulation of oxidative stress response of deregulated signaling pathways in CRC cells because this could promote new personalized therapeutic approaches to fight the disease [50].”
BackgroundWang, Q., Yang, T., Li, S., Xu, C., Wang, C., Xiong, Y., Wang, X., Wan, J., Yang, X., & Li, Z. (2023) · Research · doi:10.34133/research.0223 · Cited by 32
Wang, G., Jiang, X., Torabian, P., & Yang, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216744 · Cited by 33
Dai, H., Zhang, X., Zhao, Y., Nie, J., Hang, Z., Huang, X., Ma, H., Wang, L., Li, Z., Wu, M., et al. (2025) · Hereditas · doi:10.1186/s41065-025-00409-4 · Cited by 32
“One of the major functions of peroxisomes is to metabolize reactive oxygen species [91], which act as active second messengers in the cell and are involved in proliferation, angiogenesis, and other notorious pro-car-cinogenic processes [92].”
Wang, W.-T., Liao, S.-F., Wu, Z.-L., Chang, C., & Wu, J.-Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235717 · Cited by 36
Wang, X., He, M., Chen, X.-J., Bai, Y., & Zhou, G. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115100 · Cited by 33
Yoneda, J., Nishikawa, S., & Kurihara, S. (2021) · BMC Cancer · doi:10.1186/s12885-021-09057-z · Cited by 32
“However, excess production of ROS causes cell dysfunction such as loss of energy metabolism, disruption of cell signaling, gene mutations, tumorigenesis, immune activation, and inflammation [31, 32].”
BackgroundLi, Z., Deng, Y., Sun, H., Tan, C., Li, H., Mo, F., Wang, Y., Li, J., Zhou, Z., & Sun, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.013 · Cited by 30
Cascade strategy for glucose oxidase-based synergistic cancer therapy using nanomaterials
He, R., Yang, P., Liu, A., Zhang, Y., Chen, Y., Chang, C., & Lü, B. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01325a · Cited by 30
Chen, Y., Wang, Y., Charkoftaki, G., Orlicky, D. J., Davidson, E. A., Wan, F., Ginsberg, G., Thompson, D. C., & Vasiliou, V. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150703 · Cited by 30
Park, J. D., Kim, K.-S., Choi, S. H., Jo, G. H., Choi, J., Park, S.-W., Ko, E.-S., Lee, M., Lee, D.-K., Jang, H. J., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004825 · Cited by 31
“These data indicate that ELK3 expression levels determine mitochondrial dynamics in TNBCs, which are linked directly to mitochondrial superoxide generation and immune sensitivity to NK cells, both in vitro and in vivo.”
Oxidative Stress-Induced Gastrointestinal Diseases: Biology and Nanomedicines—A Review
Rezvani, M. (2024) · BioChem · doi:10.3390/biochem4030010 · Cited by 31
“Excessive ROS demonstrates a positive correlation with arresting the cell cycle, senescence and apoptotic condition through the signaling cascade of ASK1/JNK/p38 [13].”
Dai, H., Zhao, K., Zhao, Y., Jiang, K., Hang, Z., Huang, X., Luo, W., Nie, J., Qin, C., & Zhou, W. (2025) · BMC Urology · doi:10.1186/s12894-025-01914-4 · Cited by 29
“This finding aligns with the dual role of ROS as secondary messengers that paradoxically promote tumorigenic processes including proliferation and angiogenesis [42].”
Xu, X., Wang, C., Zhang, P., Gao, X., Guan, W., Wang, F., Li, X., Yuan, J., Dou, H., & Xu, G. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.66602 · Cited by 30
“However, to avoid ROS damage, cells eventually initiate ROS-scavenging systems by regulating a series of elimination modulators to remove ROS, such as enhancing the function of the intracellular antioxidant system [7], which leads cancer cells to resist the drug.”
BackgroundFlavonoid-based nanomedicines to target tumor microenvironment
Talib, W. H., Abuawad, A., Thiab, S. H., Alshweiat, A., & Mahmod, A. I. (2022) · OpenNano · doi:10.1016/j.onano.2022.100081 · Cited by 27
Huang, M.-W., Li, R., Yang, M., Zhou, A., Wu, H. W., Li, Z., & Wu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989139 · Cited by 29
“When reactive oxygen species (ROS) are out of balance, the potential for tumor formation is increased through the activation of oncogenic signaling pathways, immune disorders, DNA mutations, metastasis, angiogenesis, tumor microenvironment, and telomere extension (Kirtonia et al., 2020).”
BackgroundCui, Y., Zhao, T., Wang, H., Wang, X., Wang, D., & Zhang, Y. T. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.08.029 · Cited by 28
Epithelial-mesenchymal transition promotes metabolic reprogramming to suppress ferroptosis
Guo, W., Duan, Z., Wu, J., & Zhou, B. P. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.013 · Cited by 33
Verma, P., Rishi, B., George, N. G., Kushwaha, N., Dhanda, H., Kaur, M., Jain, A., Jain, A., Chaudhry, S., Singh, A., et al. (2023) · Pathology & Oncology Research · doi:10.3389/pore.2023.1611415 · Cited by 27
Cheng, W., Liu, D., Guo, M., Li, H., & Wang, Q. (2022) · Drug Development Research · doi:10.1002/ddr.21938 · Cited by 27
“In fact, there have been a large number of anticancer drugs approved by the FDA to combat cancer cells and drug resistance via promoting ROS generation (Kirtonia et al., 2020).”
BackgroundNanotechnology-integrated ferroptosis inducers: a sharp sword against tumor drug resistance
Li, C., Wu, X., Zheng, C., Xu, S., Liu, Y., Qin, J., Fan, X., Ye, Y., & Fei, W. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01350a · Cited by 26
Curcumin promotes apoptosis of human melanoma cells by caspase 3
Manica, D., da Silva, G. B., da Silva, A. P., Marafon, F., Maciel, S. F. V. D. O., Bagatini, M. D., & Moreno, M. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3863 · Cited by 26
Zhao, M., Wen, Y., Yang, Y., Pan, H., Xie, S., Shen, C., Liao, W., Chen, N., Zhang, G., Zhang, G., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155348 · Cited by 25
Nanoparticles (NPs)-mediated targeted regulation of redox homeostasis for effective cancer therapy
Zhao, Z., Cao, Y., Xu, R. F., Fang, J., Zhang, Y., Xu, X., Huang, L., & Li, R. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.03.003 · Cited by 27
Decoding mitochondria's role in immunity and cancer therapy
Zhang, Y., YAN, H. H., Wei, Y., & Wei, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189107 · Cited by 30
Tuli, H. S., Aggarwal, V., Tuorkey, M. J., Aggarwal, D., Parashar, N. C., Varol, M., Savla, R., Kaur, G., Mittal, S., & Sak, K. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105142 · Cited by 27
Osali, A., Zhiani, M., Ghaebi, M., Meymanat, M., & Esmaeilzadeh, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105094 · Cited by 25
Kim, N. Y., Jung, Y. Y., Yang, M. H., Chinnathambi, A., Govindasamy, C., Narula, A. S., Namjoshi, O. A., Blough, B. E., & Ahn, K. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.018 · Cited by 24
Weak magnetic fields modulate superoxide to control planarian regeneration
Kinsey, L. J., Huizen, A. V. V., & Beane, W. S. (2023) · Frontiers in Physics · doi:10.3389/fphy.2022.1086809 · Cited by 25
Mechanistic Insights into Toxicity of Titanium Dioxide Nanoparticles at the Micro- and Macro-levels
Chatterjee, S., & Sil, P. C. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00235 · Cited by 23
Basmadjian, O. M., Occhieppo, V. B., Marchese, N. A., Silvero, M. J., Becerra, M. C., Baiardi, G., & Bregonzio, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.647747 · Cited by 24
Li, H., Deng, N.-H., Xiao, J., & Xiu-sheng, H. (2021) · Oncology Letters · doi:10.3892/ol.2021.13031 · Cited by 25
Costa, P. S., Ramos, P. S., Ferreira, C., Silva, J. L., El‐Bacha, T., & Fialho, E. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1977834 · Cited by 23
“These compounds can inhibit NF-κB, regulate MAPKs, deplete GPX, activate JNK and p38 pathways, and increase mitochondrial membrane potential by modulating reactive oxygen species in human cancers (32).”
BackgroundMakhija, P., Handral, H. K., Mahadevan, G., Kathuria, H., Sethi, G., & Grobben, B. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114953 · Cited by 23
Self-citationEmerging roles of ferroptosis-related miRNAs in tumor metastasis
Jiang, Z., Zhou, J., Deng, J., Li, L., Wang, R., Han, Y., Zhou, J., Tao, R., Peng, L., Wang, D., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01486-y · Cited by 23
Qian, Y., Zhang, J., Xu, R., Li, Q., Shen, Q., & Zhu, G. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.05.204 · Cited by 23
Reprogramming of glycolysis by chemical carcinogens during tumor development
D’Souza, L. C., Shekher, A., Challagundla, K. B., Sharma, A., & Gupta, S. C. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.004 · Cited by 22
Protein nanoparticles as natural drugs carriers for cancer therapy
Zaher, S., Soliman, M. E. S., Elsabahy, M., & Hathout, R. M. (2022) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-022-00668-w · Cited by 22
“Normal cells are differentiated to restore their homeostatic environments to restore redox equilibrium by antioxidant enzymes or other intake antioxidant agents (Kirtonia et al. 2020).”
BackgroundTargeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Kumar, V., Bauer, C., & Stewart, J. H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00942-2 · Cited by 23
Shuvalov, O., Kirdeeva, Y., Fefilova, E., Netsvetay, S., Zorin, M., Vlasova, Y., Fedorova, O., Daks, A., Parfenyev, S., & Barlev, N. (2023) · Metabolites · doi:10.3390/metabo13050656 · Cited by 21
“ROS are known to play a multifaced, opposing role in cancer, by favoring cancer onset at low doses on the one hand, and killing tumors at high doses on the other hand [29,55].”
BackgroundElhalik, M. A., Mekky, A. E., Khedr, M., & Suleiman, W. B. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03576-y · Cited by 21
“However, an overabundance of ROS can lead to a multitude of pathological conditions, including DNA damage, carcinogenesis, and cellular degeneration, potentially triggering diseases like cancer, inflammation, lung injury, and other disorders [14, 15].”
BackgroundDeng, W., Yang, T., Dong, R., Yan, Y., & Jiang, Q. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739686 · Cited by 22
Yang, M. H., Hwang, S. T., Um, J., & Ahn, K. S. (2023) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2023.07.001 · Cited by 21
Liu, S., Hu, J., Shi, C., Sun, L., Yan, W., & Yong-sheng, S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16560 · Cited by 21
Saeed, A., Ejaz, S. A., Sarfraz, M., Tamam, N. M., Siddique, F., Riaz, N., Qais, F. A., Chtita, S., & Iqbal, J. (2022) · Molecules · doi:10.3390/molecules27133981 · Cited by 20
“Cancer development and metastasis are both aided by the stimulation of nuclear factor-kB signaling (NF-kB) by reactive oxygen species (ROS) [9].”
BackgroundJung, Y. Y., Um, J., Sethi, G., & Ahn, K. S. (2022) · Phytotherapy Research · doi:10.1002/ptr.7573 · Cited by 20
“(Dai et al., 2017; Ko et al., 2017).”
Self-citationZhang, Y., Zhang, Y., Mei, Y., Zou, R., Niu, L., & Dong, S. (2022) · Biomedicines · doi:10.3390/biomedicines10112905 · Cited by 21
“The imbalance between the elimination and generation of reactive oxygen species (ROS) is considered to be the main cause of various human diseases [1].”
BackgroundLiu, Y., Zhou, F., Yang, H., Zhang, Z., Zhang, J., He, K., Qian, M., Li, R., Sun, W., Dai, N., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101656 · Cited by 20
Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine
Jung, Y. Y., Um, J.-Y., Nasif, O., Alharbi, S. A., Sethi, G., & Ahn, K. S. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153574 · Cited by 19
Self-citationMast cells: Therapeutic targets for COVID ‐19 and beyond
Lam, H. Y., Tergaonkar, V., Kumar, A. P., & Ahn, K. S. (2021) · IUBMB Life · doi:10.1002/iub.2552 · Cited by 17
Kumar, N., Delu, V., Ulasov, I. V., Kumar, S., Singh, R. K., Kumar, S., Shukla, A., Patel, A. K., Yadav, L., Tiwari, R., et al. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01238-4 · Cited by 19
“The ability of nucleoside analogs to induce ROS has recently gained attention as an important mechanism underlying their anticancer effects [2, 3].”
InfluentialZhong, J. Q., Hua, Y., Zou, S., & Wang, B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299921 · Cited by 19
“Collectively, these results indicate that the generation of ROS by juglone plays an important role in the apoptosis and acts as an upstream regulator of PI3K/Akt pathway in NSCLC cells, which is consistent with many FDA-approved anti-neoplastic drugs in clinical applications [44].”
ResultYang, B., Cao, L., Ge, K., Lv, C., Zhao, Z., Zheng, T., Gao, S., Zhang, J., Wang, T., Jiang, J., et al. (2024) · Small · doi:10.1002/smll.202401110 · Cited by 20
Lee, J., Kang, Y., Lee, H., Saravanakumar, G., Park, S. A., Ahn, S., & Kim, W. J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122904 · Cited by 18
Regulation of apoptosis and autophagy by albendazole in human colon adenocarcinoma cells
Jung, Y. Y., Baek, S. H., Ha, I. J., & Ahn, K. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.04.014 · Cited by 20
The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer
Guo, Q., Qin, H., Liu, X., Zhang, X., Chen, Z., Qin, T., Chang, L., & Zhang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915047 · Cited by 21
“A previous study has confirmed that LAB can induce the generation of reactive oxygen species (41) which initiates cancer angiogenesis, metastasis, and survival under individual concentrations (42).”
BackgroundFerroptosis: opening up potential targets for gastric cancer treatment
Li, Y., Liu, J., Wu, S., Xiao, J., & Zhang, Z. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04886-x · Cited by 18
“These pathways' abnormal activation is crucial for the development, growth, and progression of tumors [44].”
Loss of Myo19 increases metastasis by enhancing microenvironmental ROS gradient and chemotaxis
Ren, X., Shi, P., Su, J., Wei, T., Li, J., Hu, Y., & Wu, C. (2024) · EMBO Reports · doi:10.1038/s44319-023-00052-y · Cited by 18
“ROS, which are considered as double-edge swords, are involved in tumor initiation, proliferation, invasion and angiogenesis [9] .”
DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review
Fu, X., & Wang, Z. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241259780 · Cited by 18
“Interestingly, Ras is immobilized on lipid rafts and activated by multiple factors, such as ROS, 143,144 and activated Ras further affects Mdm2 phosphorylation through the PI3K-AKT pathway.”
BackgroundNanoliposomes as nonviral vectors in cancer gene therapy
Yildiz, Ş., Entezari, M., Paskeh, M. D. A., Mirzaei, S., Kalbasi, A., Zabolian, A., Hashemi, F., Hushmandi, K., Hashemi, M., Raei, M., et al. (2024) · MedComm · doi:10.1002/mco2.583 · Cited by 18
“113,114 117 Various redox-responsive nanocarriers have been developed for cancer therapy to prolong their time in circulation and provide degradation after internalization, thus facilitating the drug and gene delivery.”
BackgroundJung, Y. Y., Kim, C., Ha, I. J., Lee, S., Lee, J., Um, J., & Ahn, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158147 · Cited by 17
Ferroptosis: Iron-mediated cell death linked to disease pathogenesis
Zhang, X., Hu, Y., Wang, B., & Yang, S. (2024) · Journal of Biomedical Research · doi:10.7555/jbr.37.20230224 · Cited by 18
Liu, J., Wu, Y., Yang, G. H., Liu, Z., & Liu, X. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.112069 · Cited by 17
In vivo optical imaging of reactive oxygen species (ROS)-related non-cancerous diseases
Gu, W., Li, S., Yang, Y., Wang, S., Li, K., Zhao, Y., Mu, J., & Chen, X. S. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117360 · Cited by 17
Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
Yang, J., & Gu, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1283465 · Cited by 19
“RT can damage DNA and inhibit GSH production, thereby promoting GPX4-mediated ferroptosis (Kirtonia et al., 2020).”
Background
Metadata
- Authors
- Kirtonia, A., Sethi, G., & Garg, M.
- Affiliations
- Amity University (IN)
- National University of Singapore (SG)
- Corresponding author
- Sethi, Gautam
- Garg, Manoj
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2020-05-01
- Volume
- 77
- Issue
- 22
- Pages
- 4459-4483
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11105050
- OpenAlex
- W3022746266
- Cited by
- 452
- References
- 257
- Citations by year
- 2026: 33 · 2025: 45 · 2024: 90 · 2023: 72 · 2022: 106 · 2021: 80 · 2020: 26
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- reactive oxygen species, carcinogenesis, redox homeostasis, oxidative stress, metastasis, angiogenesis, oncogenic signaling, DNA mutations, tumor microenvironment, cancer stem cells, drug resistance, anticancer agents, immunotherapy, radiotherapy, chemotherapy
- MeSH terms
- Animals, Humans, Neoplasm Recurrence, Local, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review